Diese Seite wurde automatisch übersetzt und die Genauigkeit der Übersetzung wird nicht garantiert. Bitte wende dich an die englische Version für einen Quelltext.

SAFER Karachi - Eine Sturzpräventionsintervention (SAFER)

8. November 2026 aktualisiert von: Sonia Sameen, Aga Khan University

SAFER Karachi: Stärkung einer adaptierten Sturzpräventionsintervention für Resilienz bei älteren Erwachsenen – eine Pilotstudie in Karachi

The goal of this pilot study is to evaluate the feasibility, acceptability, and short-term effects of a culturally adapted and strengthened fall prevention program in older adults aged 60 years and above living in urban Karachi, Pakistan. The study aims to understand whether a structured, community-based intervention can improve mobility, confidence, and overall well-being while reducing the risk of falls.

The main questions it aims to answer are:

  1. Is the adapted and strengthened fall prevention program feasible and acceptable for older adults in Karachi?
  2. Does participation in the program improve mobility, balance, fall-related self-efficacy, and psychological distress among participants?

Participants will:

  1. Take part in a 7-week group-based fall prevention program that includes strength and balance exercises, home safety education, medication awareness, and behavioral strategies
  2. Receive a home visit in Week 8 for endline assessment and evaluation of home-based adaptation and adherence
  3. Attend a booster session after 3 months to support continued engagement
  4. Complete assessments at baseline and at Week 8 (endline), including mobility, cognitive function, quality of life, and psychological distress
  5. Receive telephone follow-up calls for up to 6 months after the intervention to monitor adherence to recommended practices

Studienübersicht

Detaillierte Beschreibung

Falls are a major public health concern among older adults and are a leading cause of injury, disability, and loss of independence worldwide. The burden is particularly high in low- and middle-income countries (LMICs), where over 80% of fall-related deaths occur. In Pakistan, and especially in urban settings like Karachi, older adults face compounded risks due to limited access to geriatric care, inadequate home safety infrastructure, financial constraints, and reliance on informal caregiving systems. Despite this growing burden, fall prevention remains underexplored and under-implemented in the local context.

Most evidence-based fall prevention interventions have been developed and tested in high-income countries, raising concerns about their applicability in LMIC settings due to differences in environmental conditions, health system structures, cultural norms, and resource availability. There is a critical need to adapt and evaluate such interventions to ensure they are feasible, acceptable, and effective within the local context.

The SAFER Karachi study (Strengthening an Adapted Fall Prevention Intervention for Resilience in Older Adults) is a pilot quasi-experimental study designed to address this gap. The study aims to adapt, strengthen, and evaluate a culturally relevant fall prevention intervention for community-dwelling older adults aged 60 years and above in urban Karachi.

The intervention is based on the evidence-based Stepping On program, a multi-component fall prevention strategy that integrates strength and balance training, environmental safety education, medication awareness, and behavioural change approaches to improve self-efficacy and reduce fall risk. While the core structure of the program will be retained, context-specific adaptations and strengthening measures will be incorporated to enhance feasibility, safety, and relevance in a low-resource urban setting. These include standardized facilitator training, physiotherapist-informed delivery of exercise components, integration of supportive tools to improve adherence, and minor refinements informed by formative research and local implementation considerations.

The study will use a pre-test and post-test quasi-experimental design and will enroll approximately 75 older adults from selected urban communities in Karachi. The intervention will be delivered over a 7-week period through structured group sessions led by trained facilitators. Each session will focus on key components of fall prevention, including physical exercises, home hazard identification, medication-related risk awareness, vision and footwear considerations, and behavioral strategies to support long-term adherence. Peer interaction and social support will be emphasized to enhance engagement and sustainability.

Following the weekly group sessions, participants will receive a home visit in Week 8 for endline assessment and evaluation of home-based adaptation and adherence, followed by a booster session at 3 months post-intervention to support continued engagement. Telephone follow-ups will continue for up to 6 months post-intervention to monitor adherence to recommended practices.

The primary focus of this pilot study is to assess the feasibility and acceptability of implementing the adapted intervention in Karachi's urban community settings. Feasibility will be evaluated through indicators such as recruitment rates, retention, session attendance, and adherence to intervention components. Acceptability will be assessed through participant feedback collected in focus group discussions and facilitator evaluations, providing insights into user experience and implementation challenges.

In addition, the study will assess short-term changes in selected health and functional outcomes at baseline and endline (Week 8), including mobility and balance, fall-related self-efficacy, cognitive function, psychological distress, nutritional status, sleep quality, activities of daily living, quality of life, and adherence to home and community safety modifications. Falls will be recorded by self-report, providing preliminary data to inform future research, although the study is not powered to detect long-term reductions in fall incidence.

Data collection will include baseline and endline assessments using standardized and validated tools, as well as qualitative interviews during the formative phase and focus group discussions after the intervention to explore participant experiences, barriers, facilitators, and recommendations for improvement. These findings will be used to further refine the intervention and enhance its contextual fit.

This pilot study is designed to generate critical preliminary evidence to inform a larger, fully powered trial. By identifying key implementation challenges, participant engagement patterns, and early outcome trends, the study will contribute to the development of a scalable, culturally appropriate fall prevention model for Pakistan and similar LMIC settings.

Ultimately, the SAFER Karachi study seeks to shift the focus from reactive management of fall-related injuries to proactive, community-based prevention strategies. By improving mobility, confidence, and overall well-being among older adults, this intervention has the potential to enhance independence and quality of life while reducing the burden on families and health systems.

Studientyp

Interventionell

Einschreibung (Tatsächlich)

75

Phase

  • Unzutreffend

Kontakte und Standorte

Dieser Abschnitt enthält die Kontaktdaten derjenigen, die die Studie durchführen, und Informationen darüber, wo diese Studie durchgeführt wird.

Studienorte

    • Sindh
      • Karachi, Sindh, Pakistan, 74800
        • Aga Khan University

Teilnahmekriterien

Forscher suchen nach Personen, die einer bestimmten Beschreibung entsprechen, die als Auswahlkriterien bezeichnet werden. Einige Beispiele für diese Kriterien sind der allgemeine Gesundheitszustand einer Person oder frühere Behandlungen.

Zulassungskriterien

Studienberechtigtes Alter

60 Jahre und älter (Erwachsene, Älterer Erwachsener)

Akzeptiert gesunde Freiwillige

Ja

Studienberechtigte Geschlechter

Alle

Beschreibung

Inclusion Criteria:

  • Older adults, aged 60 years and above, residing in urban Karachi
  • Able to ambulate independently, with or without a walking stick

Exclusion Criteria:

  • Individuals who are unable to stand independently, or requiring mobility assistive devices other than a walking stick
  • Individuals who are bedbound or homebound and require full-time assistance
  • Individuals with diagnosed cognitive impairment or dementia

Studienplan

Dieser Abschnitt enthält Einzelheiten zum Studienplan, einschließlich des Studiendesigns und der Messung der Studieninhalte.

Wie ist die Studie aufgebaut?

Designdetails

  • Hauptzweck: Sonstiges
  • Zuteilung: N / A
  • Interventionsmodell: Einzelgruppenzuweisung
  • Maskierung: Keine (Offenes Etikett)

Waffen und Interventionen

Teilnehmergruppe / Arm
Intervention / Behandlung
Experimental: Intervention Arm

Participants will receive a 7-week group-based fall prevention intervention adapted for the local context. The program focuses on improving strength, balance, and safety awareness among older adults, with additional follow-up through a home visit and booster session to support sustained behaviour change.

This intervention is a culturally adapted and contextually strengthened version of the evidence-based Stepping On fall prevention program, tailored for older adults in a low-resource urban setting. Unlike standard implementations, this version incorporates context-specific modifications based on local environmental, social, and health system realities in Karachi.

Key distinguishing features include structured facilitator training to ensure standardized delivery, physiotherapist-informed guidance for exercise components to enhance safety, and integration of supportive tools to improve participant adherence and engagement. The intervention also includes follow-up reinforcement through home visits and a booster session to support sustained behaviour change.

These adaptations are designed to improve feasibility, acceptability, and scalability of the intervention within resource-constrained settings while retaining the core evidence-based components of the original program.

Was misst die Studie?

Primäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Feasibility of the Adapted Fall Prevention Intervention: Recruitment Rate
Zeitfenster: During enrollment, before the intervention starts

Proportion of eligible participants enrolled in the study. Expressed as a percentage (0-100%), with higher values indicating better feasibility.

During enrollment, before the intervention starts
Feasibility of the Adapted Fall Prevention Intervention: Retention Rate
Zeitfenster: From enrolment to endline assessment (Week 8)

Proportion of enrolled participants who complete the study. Expressed as a percentage (0-100%), with higher values indicating better feasibility.

From enrolment to endline assessment (Week 8)
Feasibility of the Adapted Fall Prevention Intervention: Session Attendance
Zeitfenster: From baseline to the end of the intervention (Weeks 1-7)

Number or proportion of intervention sessions attended by participants. Reported as a percentage or count, with higher values indicating better adherence.

From baseline to the end of the intervention (Weeks 1-7)
Feasibility of the Adapted Fall Prevention Intervention: Adherence to Intervention
Zeitfenster: From Week 1 to 6 months post-intervention

Extent to which participants follow prescribed intervention components. Reported as a proportion or score, with higher values indicating better adherence.

From Week 1 to 6 months post-intervention
Acceptability of the Adapted Fall Prevention Intervention: Acceptability Score
Zeitfenster: From baseline to the booster session, 3 months post-intervention

Measured using a Likert-scale questionnaire (e.g., 1-5), where higher scores indicate greater acceptability of the intervention.

From baseline to the booster session, 3 months post-intervention
Acceptability of the Adapted Fall Prevention Intervention: Participant Experience (Qualitative)
Zeitfenster: At the end of the intervention and follow-up (up to 1 month)

Assessed through qualitative interviews exploring participant experiences and perceptions of the intervention. Data will be analyzed thematically.

At the end of the intervention and follow-up (up to 1 month)
Acceptability of the Adapted Fall Prevention Intervention: Facilitator Evaluation
Zeitfenster: Weeks 1-7 (end of each session and end of the intervention)

Facilitator-reported acceptability will be assessed using a structured questionnaire adapted from the Acceptability of Intervention Measure (AIM), a validated 4-item scale evaluating appropriateness, satisfaction, appeal, and willingness to continue. Items are rated on a 5-point Likert scale (1 = completely disagree to 5 = completely agree). A mean score (range: 1-5) will be calculated, with higher scores indicating greater acceptability.

In addition, facilitators will complete a Structured Intervention Delivery Assessment Checklist covering ease of delivery, fidelity, and participant engagement. Items will be rated on a 5-point Likert scale (1 = poor/not at all to 5 = excellent/to a great extent). Mean domain and overall scores (range: 1-5) will be calculated, with higher scores indicating better implementation. Responses will be summarized descriptively.

Weeks 1-7 (end of each session and end of the intervention)

Sekundäre Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Short-term Functional and Psychosocial Outcomes: Activities of Daily Living (ADL)
Zeitfenster: Baseline (Week 0) and endline (Week 8)

Assessed using the Katz Index of Independence in Activities of Daily Living. Scores range from 0 to 6, with higher scores indicating greater independence.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Fall-Related Self-Efficacy
Zeitfenster: Baseline (Week 0) and endline (Week 8)

Measured using the Short Falls Efficacy Scale-International (Short FES-I). Scores range from 0 to 10 (or tool-specific range), with higher scores indicating greater confidence in performing activities without falling.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Mobility and Balance
Zeitfenster: Baseline (Week 0) and endline (Week 8)

Assessed using the Timed Up and Go (TUG) test. Performance is measured in seconds, with shorter times indicating better mobility and balance.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Nutritional Status
Zeitfenster: Baseline (Week 0) and endline (Week 8)

Measured using the Mini Nutritional Assessment-Short Form (MNA-SF). Scores range from 0 to 30, with higher scores indicating better nutritional status.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Sleep Quality
Zeitfenster: Baseline (Week 0) and endline (Week 8)

Assessed using the Pittsburgh Sleep Quality Index-Short (PSQI-Short). Scores range from 0 to 21, with higher scores indicating poorer sleep quality.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Quality of Life
Zeitfenster: Baseline (Week 0) and endline (Week 8)

Measured using the Older People's Quality of Life Questionnaire (OPQOL). Domain scores range from 0 to 100, with higher scores indicating better quality of life.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Cognitive Function
Zeitfenster: Baseline (Week 0) and endline (Week 8)

Assessed using the Mini Montreal Cognitive Assessment (Mini MoCA). Scores range from 0 to 30, with higher scores indicating better cognitive function.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Psychological Distress
Zeitfenster: Baseline (Week 0) and endline (Week 8)

Measured using the Kessler Psychological Distress Scale (K10). Scores range from 10 to 50, with higher scores indicating greater psychological distress.

Baseline (Week 0) and endline (Week 8)
Short-term Functional and Psychosocial Outcomes: Adherence to Safety Modifications
Zeitfenster: Baseline (Week 0) and endline (Week 8)

Adherence to recommended home and community safety modifications will be assessed using a structured Self-Reported Safety Modification Adherence Checklist developed for this study based on standard fall prevention guidelines from multiple sources, including the Otago guidelines, WHO, and more. The checklist will include multiple items covering home environment modifications, use of assistive devices, and safe mobility practices. Each item will be scored as 0 (not implemented), 1 (partially implemented), or 2 (fully implemented).

A total adherence score will be calculated by summing item responses, with scores ranging from 0 to the maximum possible based on applicable items; higher scores indicate greater adherence. Adherence may also be expressed as a proportion (%) of recommended modifications implemented.

Baseline (Week 0) and endline (Week 8)

Andere Ergebnismessungen

Ergebnis Maßnahme
Maßnahmenbeschreibung
Zeitfenster
Fall Incidence
Zeitfenster: Baseline, Week 8 (endline), booster session (3 months post-intervention), and up to 6 months post-intervention

Number of self-reported falls (ProFaNE consensus definition of falls)

Baseline, Week 8 (endline), booster session (3 months post-intervention), and up to 6 months post-intervention

Mitarbeiter und Ermittler

Hier finden Sie Personen und Organisationen, die an dieser Studie beteiligt sind.

Ermittler

  • Hauptermittler: Sonia Sameen, MSc., Aga Khan University

Publikationen und hilfreiche Links

Die Bereitstellung dieser Publikationen erfolgt freiwillig durch die für die Eingabe von Informationen über die Studie verantwortliche Person. Diese können sich auf alles beziehen, was mit dem Studium zu tun hat.

Studienaufzeichnungsdaten

Diese Daten verfolgen den Fortschritt der Übermittlung von Studienaufzeichnungen und zusammenfassenden Ergebnissen an ClinicalTrials.gov. Studienaufzeichnungen und gemeldete Ergebnisse werden von der National Library of Medicine (NLM) überprüft, um sicherzustellen, dass sie bestimmten Qualitätskontrollstandards entsprechen, bevor sie auf der öffentlichen Website veröffentlicht werden.

Haupttermine studieren

Studienbeginn (Tatsächlich)

1. September 2025

Primärer Abschluss (Tatsächlich)

30. Juni 2026

Studienabschluss (Tatsächlich)

31. August 2026

Studienanmeldedaten

Zuerst eingereicht

19. März 2026

Zuerst eingereicht, das die QC-Kriterien erfüllt hat

27. März 2026

Zuerst gepostet (Tatsächlich)

31. März 2026

Studienaufzeichnungsaktualisierungen

Letztes Update gepostet (Tatsächlich)

12. November 2026

Letztes eingereichtes Update, das die QC-Kriterien erfüllt

8. November 2026

Zuletzt verifiziert

1. Oktober 2026

Mehr Informationen

Begriffe im Zusammenhang mit dieser Studie

Plan für individuelle Teilnehmerdaten (IPD)

Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?

JA

Beschreibung des IPD-Plans

De-identified individual participant data (IPD) underlying the results reported in this study will be made available to qualified researchers upon reasonable request. Data will be shared after publication of the primary study results and will include variables necessary to reproduce the findings.

All data sharing will be subject to approval by the principal investigator and the Aga Khan University Ethics Review Committee, and will require a data sharing agreement to ensure confidentiality, ethical use, and compliance with institutional policies.

IPD-Sharing-Zeitrahmen

Data will be available beginning 6 months after publication of the primary results and will remain available for up to 3 years.

IPD-Sharing-Zugriffskriterien

Access will be granted to researchers with a methodologically sound proposal. Requests should be directed to the principal investigator and will be reviewed based on scientific merit, ethical considerations, and feasibility.

Art der unterstützenden IPD-Freigabeinformationen

  • STUDIENPROTOKOLL
  • SAFT

Arzneimittel- und Geräteinformationen, Studienunterlagen

Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt

Nein

Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt

Nein

Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .

Abonnieren